EP1216319A1 - Absorbierender stoff - Google Patents
Absorbierender stoffInfo
- Publication number
- EP1216319A1 EP1216319A1 EP00960844A EP00960844A EP1216319A1 EP 1216319 A1 EP1216319 A1 EP 1216319A1 EP 00960844 A EP00960844 A EP 00960844A EP 00960844 A EP00960844 A EP 00960844A EP 1216319 A1 EP1216319 A1 EP 1216319A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- yarn
- gel
- forming
- fabric
- reinforcing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000004744 fabric Substances 0.000 title claims abstract description 80
- 230000003014 reinforcing effect Effects 0.000 claims abstract description 46
- 239000002243 precursor Substances 0.000 claims abstract description 25
- 239000002131 composite material Substances 0.000 claims abstract description 21
- 239000000835 fiber Substances 0.000 claims abstract description 16
- 238000009954 braiding Methods 0.000 claims abstract description 12
- 238000009940 knitting Methods 0.000 claims abstract description 12
- 238000009941 weaving Methods 0.000 claims abstract description 12
- 238000004519 manufacturing process Methods 0.000 claims abstract description 4
- 239000000463 material Substances 0.000 claims description 33
- 238000000034 method Methods 0.000 claims description 22
- 230000002439 hemostatic effect Effects 0.000 claims description 20
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 14
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 10
- 239000011734 sodium Substances 0.000 claims description 10
- 229910052708 sodium Inorganic materials 0.000 claims description 10
- 210000004369 blood Anatomy 0.000 claims description 8
- 239000008280 blood Substances 0.000 claims description 8
- 239000004677 Nylon Substances 0.000 claims description 7
- 239000012530 fluid Substances 0.000 claims description 7
- 229920001778 nylon Polymers 0.000 claims description 7
- 210000001124 body fluid Anatomy 0.000 claims description 6
- 239000010839 body fluid Substances 0.000 claims description 6
- 239000000648 calcium alginate Substances 0.000 claims description 4
- 235000010410 calcium alginate Nutrition 0.000 claims description 4
- 229960002681 calcium alginate Drugs 0.000 claims description 4
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 claims description 4
- 239000002250 absorbent Substances 0.000 claims description 2
- 230000002745 absorbent Effects 0.000 claims description 2
- 239000002759 woven fabric Substances 0.000 claims description 2
- 239000002657 fibrous material Substances 0.000 claims 1
- 235000004879 dioscorea Nutrition 0.000 description 18
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 14
- 239000001768 carboxy methyl cellulose Substances 0.000 description 14
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 13
- 238000006243 chemical reaction Methods 0.000 description 11
- 229920002678 cellulose Polymers 0.000 description 7
- 239000001913 cellulose Substances 0.000 description 7
- 239000000499 gel Substances 0.000 description 7
- 230000000740 bleeding effect Effects 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 229920002201 Oxidized cellulose Polymers 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 229940030225 antihemorrhagics Drugs 0.000 description 3
- 239000002874 hemostatic agent Substances 0.000 description 3
- 229940107304 oxidized cellulose Drugs 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 2
- 229920000433 Lyocell Polymers 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229920002994 synthetic fiber Polymers 0.000 description 2
- 241001474374 Blennius Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920001131 Pulp (paper) Polymers 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000012779 reinforcing material Substances 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- D—TEXTILES; PAPER
- D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
- D04B—KNITTING
- D04B1/00—Weft knitting processes for the production of fabrics or articles not dependent on the use of particular machines; Fabrics or articles defined by such processes
- D04B1/10—Patterned fabrics or articles
- D04B1/12—Patterned fabrics or articles characterised by thread material
-
- D—TEXTILES; PAPER
- D03—WEAVING
- D03D—WOVEN FABRICS; METHODS OF WEAVING; LOOMS
- D03D3/00—Woven fabrics characterised by their shape
- D03D3/02—Tubular fabrics
-
- D—TEXTILES; PAPER
- D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
- D04B—KNITTING
- D04B1/00—Weft knitting processes for the production of fabrics or articles not dependent on the use of particular machines; Fabrics or articles defined by such processes
- D04B1/10—Patterned fabrics or articles
- D04B1/12—Patterned fabrics or articles characterised by thread material
- D04B1/123—Patterned fabrics or articles characterised by thread material with laid-in unlooped yarn, e.g. fleece fabrics
-
- D—TEXTILES; PAPER
- D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B2201/00—Cellulose-based fibres, e.g. vegetable fibres
-
- D—TEXTILES; PAPER
- D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B2331/00—Fibres made from polymers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polycondensation products
- D10B2331/02—Fibres made from polymers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polycondensation products polyamides
-
- D—TEXTILES; PAPER
- D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B2401/00—Physical properties
- D10B2401/06—Load-responsive characteristics
- D10B2401/063—Load-responsive characteristics high strength
-
- D—TEXTILES; PAPER
- D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B2403/00—Details of fabric structure established in the fabric forming process
- D10B2403/01—Surface features
- D10B2403/011—Dissimilar front and back faces
- D10B2403/0114—Dissimilar front and back faces with one or more yarns appearing predominantly on one face, e.g. plated or paralleled yarns
-
- D—TEXTILES; PAPER
- D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B2509/00—Medical; Hygiene
- D10B2509/02—Bandages, dressings or absorbent pads
- D10B2509/022—Wound dressings
Definitions
- the present invention pertains to fabrics that are capable of
- fabrics are particularly useful for the control of bleeding.
- materials including yarns, which gel when wet and which absorb body fluids.
- Such materials are used as swabs during surgery, as hemostatic agents and
- CMC carboxymethylcellulose
- CMC as wound dressings.
- CMC gels upon contact with water, blood or body fluids,
- CMC also facilitates blood clotting while
- a composite structure incorporating gel-forming fibres
- fibres are gelled.
- the present invention provides a composite knit, woven or braided
- reinforcing yarn is knit, woven or braided such that the fabric is
- the gel-forming yarn in one embodiment of the present invention, the gel-forming yarn
- hemostatic material such as sodium carboxymethylcellulose
- the reinforcing yarn is a thin strong synthetic material
- forming yarn may follow the same yarn path as some or all of the reinforcing
- the gel-forming yarn may also follow a different path by which it
- the fabric may be made by
- a gel-forming yam such as oxidized cellulose or CMC.
- a gel-forming yam such as oxidized cellulose or CMC.
- a fabric may be made by weaving, knitting or braiding, with a reinforcing yarn, a cellulosic yarn, the woven, knit or braided structure being such that the
- reinforcing yam be resistant to chemical attack in the conversion process.
- cellulosic yam thus converted is in fact gel-forming, highly absorptive and may
- the resultant fluid absorbing fabric is stretchable, to
- the degree the reinforcing yarn and/or the structure of the fabric is stretchable.
- gel-forming yarn has absorbed water or blood or body fluid and formed a gel
- Such a composite yarn may comprise
- core fibre is a continuous strand of a reinforcing filament, or filaments, made of
- Figure 1 is a diagrammatic view of one knitted embodiment of the
- Figure 2 is a diagrammatic view of another knitted embodiment of
- the present invention in one embodiment, comprises a composite
- hemostatic refers to a material that
- Some gel-forming materials such as CMC are examples of CMC.
- the term "reinforcing" yarn refers to a yarn that has greater tensile strength in a wet phase than a gel-forming yam with which it is
- material suitable for weaving, knitting or braiding typically comprised of one or
- Gel-forming materials or yarns of the type generally referred to
- Such a material absorbs liquid and
- hemostatic because they tend to cause blood to clot
- Hemostatic, gel-forming materials such as CMC
- the composite fabric of the present invention comprises a
- the reinforcing yarn is a relatively strong synthetic material, with which the gel-
- forming yarn is placed side by side during the weaving, knitting or braiding of
- the gel-forming and reinforcing yams into a woven, knitted or braided fabric.
- all or less than all of the yam courses of the reinforcing yarn may
- woven or knitted fabric may comprise gel-forming yarn only, so
- the gel-forming yarns have gelled.
- at least 5% by
- yarn may be used to yield a fabric of greater strength.
- Lyocell is a solvent spun cellulose
- the filaments in such a yarn may be chopped into staple form and
- unconverted cellulose yam is readily woven, knit or braided into a precursor
- ceUulose buUding blocks may be converted to the sodium
- W Ue the present invention is not limited to sodium carboxymethylceUulose of
- a hemostatic agent during surgery may also be used in the reinforced fabric of
- the present invention and may also be converted (oxidized) after cellulosic yarn
- hemostatic material useful in the present invention.
- calcium alginate which is a material derived from seaweed, and, in matted fibre form, is also used as a wound dressing.
- Other fibrous polysaccharides with
- simUar chemistry and properties to CMC may also be used.
- each of the multiple yarn end feeds to a weaving loom
- knitting machine or braiding machine may comprise, in effect, two yam ends
- one the gel-forming yarn (or a precursor yarn suitable for
- a thicker (but weaker) yarn 1 which is either a gel-forming fibre or is convertible to a gel-forming yarn (i.e. a gel-forming
- Reinforcing yarns 3 are knit so as to provide structural integrity to
- the inlaying of gel-forming yarns 4 is such that even if the gel-
- Knit forms of the composite fabric of this invention have some
- the reinforcing yarn itself may be stretchable so that the fabric itself
- invention is as a hemostatic shroud covering an expansible device, adapted for
- precursor yam (12 tex lyoceU spun yam is knit together with a
- the loop length is 5
- the reinforcing yam comprises about
- invention also includes the process of making a gel-forming or hemostatic
- stmcture including a matted fibre or laid-in knit stmcture, as disclosed in the above-referenced WO 98/46818, by first forming the stmcture with gel-forming
- fibre precursors such as ceUulose fibre or yarn
- fibres such as nylon, and gel-forming fibres (or precursors thereof).
- a preferred example of such a composite yarn is a core spun yarn
- preformed yam may be another spun yarn, or, more commonly, a continuous
- This preformed yarn may comprise a reinforcing material, such as
- Gel-forming, or precursors of gel-forming, fibres comprise a second
- the preformed yarn provide strength.
- Such a yarn may be woven, knit or
Landscapes
- Engineering & Computer Science (AREA)
- Textile Engineering (AREA)
- Materials For Medical Uses (AREA)
- Woven Fabrics (AREA)
- Knitting Of Fabric (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40649099A | 1999-09-27 | 1999-09-27 | |
| US406490 | 1999-09-27 | ||
| US61203800A | 2000-07-07 | 2000-07-07 | |
| US612038 | 2000-07-07 | ||
| PCT/GB2000/003586 WO2001023653A1 (en) | 1999-09-27 | 2000-09-19 | Absorptive fabric |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP1216319A1 true EP1216319A1 (de) | 2002-06-26 |
| EP1216319B1 EP1216319B1 (de) | 2004-04-07 |
Family
ID=27019535
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP00960844A Expired - Lifetime EP1216319B1 (de) | 1999-09-27 | 2000-09-19 | Absorbierender stoff |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1216319B1 (de) |
| JP (1) | JP2003510475A (de) |
| CN (1) | CN1214141C (de) |
| AT (1) | ATE263858T1 (de) |
| AU (1) | AU771967B2 (de) |
| CA (1) | CA2384689C (de) |
| DE (1) | DE60009727T2 (de) |
| ES (1) | ES2222231T3 (de) |
| WO (1) | WO2001023653A1 (de) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2153807A1 (de) | 2008-08-15 | 2010-02-17 | Birgit Riesinger | Wundpflegeartikel, aufweisend Textilbänder mit Fasern mit gelbildenden Eigenschaften sowie Fasern mit nicht gelbildenden Eigenschaften |
| EP2790626A4 (de) * | 2011-12-09 | 2015-08-05 | Covidien Lp | Nichthaftende wundverbände und zugehörige verfahren |
| US9402770B2 (en) | 2011-12-09 | 2016-08-02 | Covidien | Antimicrobial non-adherent dressings and related methods therefor |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0030794D0 (en) * | 2000-12-16 | 2001-01-31 | Hudson John O | Medical device and use thereof |
| ATE533516T1 (de) | 2002-04-04 | 2011-12-15 | Univ Akron Akron Ohio | Nichtgewebte faserverbände |
| US8367570B2 (en) | 2002-04-04 | 2013-02-05 | The University Of Akron | Mechanically strong absorbent non-woven fibrous mats |
| US7252837B2 (en) | 2002-06-28 | 2007-08-07 | Ethicon, Inc. | Hemostatic wound dressing and method of making same |
| US7279177B2 (en) | 2002-06-28 | 2007-10-09 | Ethicon, Inc. | Hemostatic wound dressings and methods of making same |
| US20040265371A1 (en) | 2003-06-25 | 2004-12-30 | Looney Dwayne Lee | Hemostatic devices and methods of making same |
| GB2409162B (en) * | 2004-10-06 | 2005-12-14 | Bhk Holding Ltd | Materials,methods,and apparatus for treating a body cavity |
| US9358318B2 (en) | 2004-10-20 | 2016-06-07 | Ethicon, Inc. | Method of making a reinforced absorbable multilayered hemostatic wound dressing |
| EP1809343B1 (de) | 2004-10-20 | 2012-08-15 | Ethicon, Inc. | Verstärkter resorbierbarer mehrschichtiger hämostatischer wundverband und herstellungsverfahren |
| KR20130060276A (ko) | 2004-10-20 | 2013-06-07 | 에디컨인코포레이티드 | 의료 장치에 사용하기 위한 강화 흡수성 다층 직물 및 이의 제조방법 |
| GB0513555D0 (en) * | 2005-07-01 | 2005-08-10 | Bristol Myers Squibb Co | Carboxymethylated cellulosic wound dressing garment |
| GB0513552D0 (en) * | 2005-07-01 | 2005-08-10 | Bristol Myers Squibb Co | Bandage |
| GB0525504D0 (en) | 2005-12-14 | 2006-01-25 | Bristol Myers Squibb Co | Antimicrobial composition |
| US20090074837A1 (en) * | 2007-09-19 | 2009-03-19 | Ut-Battelle, Llc | Bioresorbable Calcium-Deficient Hydroxyapatite Hydrogel Composite |
| GB0808376D0 (en) * | 2008-05-08 | 2008-06-18 | Bristol Myers Squibb Co | Wound dressing |
| GB201020236D0 (en) | 2010-11-30 | 2011-01-12 | Convatec Technologies Inc | A composition for detecting biofilms on viable tissues |
| US9103065B2 (en) * | 2011-09-12 | 2015-08-11 | Gunze Limited | Method for producing hydrophilic cellulose fiber |
| US20140309574A1 (en) * | 2011-11-01 | 2014-10-16 | Brightwake Limited | Wound dressings, and yarn useful therein |
| GB201120693D0 (en) | 2011-12-01 | 2012-01-11 | Convatec Technologies Inc | Wound dressing for use in vacuum therapy |
| WO2013096091A1 (en) * | 2011-12-21 | 2013-06-27 | Kci Licensing, Inc. | A wound filler having dynamic motion |
| CN103668617B (zh) * | 2012-08-31 | 2016-12-21 | 康力得生技股份有限公司 | 天然高分子纱线及其制造方法、网状织物与应用 |
| US20150354096A1 (en) | 2012-12-20 | 2015-12-10 | Convatec Technologies Inc. | Processing of chemically modified cellulosic fibres |
| JPWO2015099083A1 (ja) | 2013-12-25 | 2017-03-23 | 日産化学工業株式会社 | 血清および血液を固化する水分散液 |
| CN103741261B (zh) * | 2014-01-13 | 2016-05-04 | 大连工业大学 | 海藻酸钙/聚乙二醇酯双网络相变储能纤维及其制备方法 |
| JP6774738B2 (ja) * | 2015-04-15 | 2020-10-28 | スリーエム イノベイティブ プロパティズ カンパニー | 面ファスナ雌材、面ファスナ、及び吸収性物品 |
| CN108498840A (zh) * | 2018-01-17 | 2018-09-07 | 惠州华阳医疗器械有限公司 | 一种伤口敷料及其制备方法 |
| CN114351335B (zh) * | 2021-12-22 | 2024-03-15 | 安丹达工业技术(上海)有限公司 | 水凝胶三维间隔纺织材料及其应用和包含其的口罩 |
| CN114753047B (zh) * | 2022-04-27 | 2023-09-22 | 厦门和新科技有限公司 | 鱼鳞蛋白改性的锦氨亲肤面料及其加工工艺 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3561441A (en) * | 1967-08-10 | 1971-02-09 | Victor J Lombardi | Surgical product for dressing and treating wounds, and method of manufacture |
| DE3100466A1 (de) * | 1981-01-09 | 1982-09-02 | SNIA Viscosa Società Nazionale Industria Applicazioni Viscosa S.p.A., Milano | Strickkleidung und verfahren zu ihrer herstellung |
| AU684454B2 (en) * | 1992-01-24 | 1997-12-18 | Societe Precis | Dressing material having a polymeric fibre core |
| GB9618565D0 (en) * | 1996-09-05 | 1996-10-16 | Bristol Myers Co | Wound dressing |
| JP4267694B2 (ja) * | 1997-04-11 | 2009-05-27 | ブリストルーマイヤーズ スクイブ カンパニー | 編まれた創傷ドレッシング及びその製造方法 |
| NL1005812C1 (nl) * | 1997-04-15 | 1997-06-04 | Claus Jurgen Timmermans | Superabsorberend wondverband. |
| GB9812329D0 (en) * | 1998-06-08 | 1998-08-05 | Courtaulds Plc | Yarns and wound dressings containing the same |
-
2000
- 2000-09-19 ES ES00960844T patent/ES2222231T3/es not_active Expired - Lifetime
- 2000-09-19 AU AU73013/00A patent/AU771967B2/en not_active Expired
- 2000-09-19 EP EP00960844A patent/EP1216319B1/de not_active Expired - Lifetime
- 2000-09-19 WO PCT/GB2000/003586 patent/WO2001023653A1/en active IP Right Grant
- 2000-09-19 JP JP2001527027A patent/JP2003510475A/ja active Pending
- 2000-09-19 CN CNB008132593A patent/CN1214141C/zh not_active Expired - Lifetime
- 2000-09-19 AT AT00960844T patent/ATE263858T1/de not_active IP Right Cessation
- 2000-09-19 DE DE60009727T patent/DE60009727T2/de not_active Expired - Lifetime
- 2000-09-19 CA CA002384689A patent/CA2384689C/en not_active Expired - Lifetime
Non-Patent Citations (1)
| Title |
|---|
| See references of WO0123653A1 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2153807A1 (de) | 2008-08-15 | 2010-02-17 | Birgit Riesinger | Wundpflegeartikel, aufweisend Textilbänder mit Fasern mit gelbildenden Eigenschaften sowie Fasern mit nicht gelbildenden Eigenschaften |
| DE102008037888A1 (de) | 2008-08-15 | 2010-02-25 | Birgit Riesinger | Wundpflegeartikel, aufweisend Textilbänder mit Fasern mit gelbildenden Eigenschaften sowie Fasern mit nicht gelbildenden Eigenschaften |
| EP2790626A4 (de) * | 2011-12-09 | 2015-08-05 | Covidien Lp | Nichthaftende wundverbände und zugehörige verfahren |
| US9402770B2 (en) | 2011-12-09 | 2016-08-02 | Covidien | Antimicrobial non-adherent dressings and related methods therefor |
Also Published As
| Publication number | Publication date |
|---|---|
| DE60009727T2 (de) | 2004-08-12 |
| CN1214141C (zh) | 2005-08-10 |
| CA2384689A1 (en) | 2001-04-05 |
| EP1216319B1 (de) | 2004-04-07 |
| CA2384689C (en) | 2009-05-12 |
| DE60009727D1 (de) | 2004-05-13 |
| AU771967B2 (en) | 2004-04-08 |
| WO2001023653A1 (en) | 2001-04-05 |
| ATE263858T1 (de) | 2004-04-15 |
| AU7301300A (en) | 2001-04-30 |
| JP2003510475A (ja) | 2003-03-18 |
| ES2222231T3 (es) | 2005-02-01 |
| CN1376221A (zh) | 2002-10-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1216319B1 (de) | Absorbierender stoff | |
| JP6556814B2 (ja) | 真空療法で使用するための創傷被覆材 | |
| AU2002223842B2 (en) | Hemostatic device | |
| CA2256644C (en) | Knitted wound dressings and method for making same | |
| CN103974680B (zh) | 不粘附的伤口敷料及其相关方法 | |
| AU2002223842A1 (en) | Hemostatic device | |
| AU2002223842A2 (en) | Hemostatic device | |
| EP2898903A1 (de) | Hochhygroskopischer wundverband und herstellungsverfahren und verwendung davon | |
| CN103857414A (zh) | 创伤敷料及其相关方法 | |
| US20210137742A1 (en) | High hygroscopic wound dressing and preparation method and use thereof | |
| NZ626694B2 (en) | Wound dressing for use in vacuum therapy | |
| NZ332977A (en) | Knitted wound dressing comprising gel-forming fibres |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20020308 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
| AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
| 17Q | First examination report despatched |
Effective date: 20030603 |
|
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: HUDSON, JOHN OVERTON |
|
| GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
| GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
| AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20040407 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20040407 Ref country code: CH Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20040407 Ref country code: LI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20040407 Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20040407 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20040407 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20040407 |
|
| REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
| REF | Corresponds to: |
Ref document number: 60009727 Country of ref document: DE Date of ref document: 20040513 Kind code of ref document: P |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20040707 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20040707 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20040707 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20040919 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20040920 |
|
| LTIE | Lt: invalidation of european patent or patent extension |
Effective date: 20040407 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20040930 |
|
| NLV1 | Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act | ||
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
| ET | Fr: translation filed | ||
| REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2222231 Country of ref document: ES Kind code of ref document: T3 |
|
| PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
| 26N | No opposition filed |
Effective date: 20050110 |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
| REG | Reference to a national code |
Ref country code: GB Ref legal event code: 732E |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20040907 |
|
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 17 |
|
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 18 |
|
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 19 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20190903 Year of fee payment: 20 Ref country code: IT Payment date: 20190917 Year of fee payment: 20 Ref country code: FR Payment date: 20190815 Year of fee payment: 20 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20190920 Year of fee payment: 20 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20191001 Year of fee payment: 20 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R071 Ref document number: 60009727 Country of ref document: DE |
|
| REG | Reference to a national code |
Ref country code: GB Ref legal event code: PE20 Expiry date: 20200918 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20200918 |
|
| REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20220103 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20200920 |